Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Option Award | 2024-02-29 5:07 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 564,000 | $0 | 564,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:37 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:19 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 3,600,000 | $0 | 3,600,000 (Direct) | View |
| 2021-06-30 Ownership | 2022-02-11 5:18 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 18,248 | $0.58 | 19,645 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 5:52 pm | 2022-02-23 2031-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 1,080,000 | $0 | 1,080,000 (Direct) | View |
| 2020-01-06 Ownership | 2021-02-12 5:32 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 493 | $1.02 | 1,397 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-06 6:26 pm | 2021-05-04 2030-05-04 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 720,000 | $0 | 720,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 4:24 pm | 2021-02-25 2030-02-25 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2019-02-17 Ownership | 2020-02-14 4:14 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 59 | $17.85 | 904 (Direct) | View |
| 2019-07-31 Ownership | 2020-02-14 4:14 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 815 | $11.82 | 904 (Direct) | View |